Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis
- PMID: 2584936
- PMCID: PMC2189541
- DOI: 10.1084/jem.170.6.2097
Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis
Abstract
The ability of mice to resist infection with L. major correlated directly with the capacity of their LNC to produce TNF in response to in vitro parasite challenge. Blocking TNF in vivo by passively administering anti-TNF antibodies exacerbated the course of L. major infection, resulting in substantially larger cutaneous lesions and elevated numbers of parasites within those lesions. In addition, treatment of infected mice with exogenous rHuTNF afforded host protection as evidenced by smaller lesion size and decreased parasite counts. Taken together, these results suggest a central role for TNF in resistance to L. major.
Similar articles
-
Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis.Immunology. 1990 Apr;69(4):570-3. Immunology. 1990. PMID: 2335376 Free PMC article.
-
Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo.Infect Immun. 1991 Aug;59(8):2839-42. doi: 10.1128/iai.59.8.2839-2842.1991. Infect Immun. 1991. PMID: 1906844 Free PMC article.
-
Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.J Immunol. 1986 Jan;136(2):655-61. J Immunol. 1986. PMID: 3079789
-
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.J Immunol. 1989 Jul 1;143(1):266-74. J Immunol. 1989. PMID: 2499629
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
Cited by
-
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells.Infect Immun. 2004 Mar;72(3):1298-305. doi: 10.1128/IAI.72.3.1298-1305.2004. Infect Immun. 2004. PMID: 14977931 Free PMC article.
-
Response of Leishmania chagasi promastigotes to oxidant stress.Infect Immun. 1994 Nov;62(11):5133-41. doi: 10.1128/iai.62.11.5133-5141.1994. Infect Immun. 1994. PMID: 7927797 Free PMC article.
-
Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.Infection. 1999 Jan-Feb;27(1):1-11. doi: 10.1007/BF02565163. Infection. 1999. PMID: 10027099 Review. No abstract available.
-
IL-4-deficient Balb/c mice resist infection with Leishmania major.J Exp Med. 1996 Sep 1;184(3):1127-36. doi: 10.1084/jem.184.3.1127. J Exp Med. 1996. PMID: 9064329 Free PMC article.
-
Protective immunity and vaccination against cutaneous leishmaniasis.Front Immunol. 2012 May 29;3:128. doi: 10.3389/fimmu.2012.00128. eCollection 2012. Front Immunol. 2012. PMID: 22661975 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical